Microendoscopic transventricular deep brain stimulation of the anterior nucleus of the thalamus as a safe treatment in intractable epilepsy: A feasibility study

• Published in: Revue neurologique Vol. 178; no. 9; pp. 886 - 895
• Main Authors: Poulen, G., Rolland, A., Chan-Seng, E., Sanrey, E., Gélisse, P., Crespel, A., Coubes, P.
• Format: Journal Article
• Language: English
• Published: Elsevier Masson SAS 01.11.2022; Elsevier Masson
• Subjects: Adult; Anterior Thalamic Nuclei; Cognitive science; Deep Brain Stimulation; Drug Resistant Epilepsy; Endoscopy; Epilepsy surgery; Feasibility Studies; Humans; Neuromodulation; Neuroscience; Neurosurgery; Quality of Life; Retrospective Studies; Stereotactic surgery; Stereotactic surgery; Neurosurgery; Endoscopy; Epilepsy surgery; Deep brain stimulation; Neuromodulation
• ISSN: 0035-3787
• DOI: 10.1016/j.neurol.2022.03.023

Deep brain stimulation (DBS) of the anterior nucleus of the thalamus (ANT) is proposed in patients with severe intractable epilepsy. When used, the transventricular approach increases the risk of bleeding due the anatomy around the entry point in the thalamus. To avoid such a complication, we used a transventricular microendoscopic technique. We performed a retrospective study of nine adult patients who were surgically treated for refractory epilepsy between 2010 and 2019 by DBS of the anterior thalamic nucleus. Endoscopy provides a direct visual control of the entry point of the lead in the thalamus through the ventricle by avoiding ependymal vessels. No hemorrhage was recorded and accuracy was systematically checked by intraoperative stereotactic MRI. We reported a responder rate improvement in 88.9% of patients at 1 year and in 87.5% at 2 years. We showed a significant decrease in global seizure count per month one year after DBS (68.1%; P=0.013) leading to an overall improvement in quality of life. No major adverse effect was recorded during the follow-up. ANT DBS showed a prominent significant effect with a decrease of the number of generalized seizures. We aimed at a better ANT/lead collimation using a vertical transventricular approach under microendoscopic monitoring. This technique permitted to demonstrate the safety and the accuracy of the procedure.